Keyphrases
Major Depressive Disorder
100%
Depressed Patients
94%
Abdominal Obesity
92%
Treatment as Usual
92%
Randomized Clinical Trial
92%
Cardiovascular Risk
92%
Risk Reduction
92%
Care Coordination
92%
Acute Exercise
81%
Clinical Depression
80%
Healthy Controls
79%
Patients with Depression
68%
Schizophrenia Spectrum Disorders
57%
Intervention Effect
52%
Exercise Effect
51%
Infectious Diseases
46%
Interleukin-6
46%
Schizophrenia
46%
Electroconvulsive Therapy
46%
Unipolar Depression
46%
Growth Hormone
46%
Drug Trials
46%
Non-drug
46%
Systematic Meta-analysis
46%
Symptom Severity
46%
Autoimmune Disease
46%
Depressive Symptoms
46%
Prolactin
46%
Systematic Error
46%
Mood Disorders
46%
Atrial Natriuretic Peptide
46%
Severe Infection
46%
Cognitive Function
46%
Inflammation
46%
Copeptin
46%
Risk Factors
46%
Symptom Response
46%
Cortisol Reactivity
46%
Hormone Response
46%
Response Exercise
46%
Meta-analysis of Randomized Controlled Trials
46%
NT-proANP
46%
Patient-controlled
46%
RNA Damage
46%
Standardized Mean Difference
34%
Cortisol
33%
Intention-to-treat Analysis
32%
Risk of Bias
32%
Exercise Intervention
32%
Patients with Schizophrenia
31%
Medicine and Dentistry
Cardiovascular Disease
92%
Abdominal Obesity
92%
Care Coordination
92%
Randomized Clinical Trial
92%
Schizophrenia Spectrum Disorder
57%
DNA RNA Hybridization
46%
Electroconvulsive Therapy
46%
Depressive Disorder
46%
Major Depressive Episode
46%
Drug Screening
46%
Somatics
36%
Life Expectancy
32%
Outcome Assessment
25%
Comorbidity
23%
General Practitioner
23%
Mortality
20%
Population
20%
Physical Disease
20%
Cardiovascular Risk
18%
